Key Dates

Related Announcements

• September 10, 2025 - Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional). See NOFO PAR-25-446
• July 12, 2024 - Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional). See NOFO PAR-25-023

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to alert applicants of the early expiration of PAR-25-023, "Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional)". The Notice of Funding Opportunity (NOFO), PAR-25-023, will be expired early, effective immediately. No further applications will be accepted for consideration under this NOFO.  Applicants are encouraged to apply using the NOFO PAR-25-446 (Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional). 

Inquiries

Please direct all inquiries to:

Will M. Aklin, Ph.D.
National Institute on Drug Abuse (NIDA)
Phone: 301-827-5909
Email: [email protected]

Katrina Foster, Ph.D.
National Institute on Drug Abuse (NIDA)
Phone: 301-827-5815
Email: [email protected]